Monitoring of antibiotic resistance in bacterial isolates from bacteremic patients

Journal of Chemotherapy

Volumn 16, Issue 3, 2004, Pages 269-272

  Blahova J ^a   Kralikova K ^a   Krcmery Sr V ^a   Babalova M ^a   Menkyna, R ^a   Glosova L ^b   Knotkova H ^c   Liskova A ^d   Molokacova M ^e   Vaculikova A ^f  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b Hospital Tren ín   (Slovakia)

^c Martinska Fakultna Nemocnica   (Slovakia)

^d University Hospital Nitra   (Slovakia)

^e L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^f Derer 's University Hospital Slovakia   (Slovakia)

Author keywords

Antibiotic resistance; Bacteremia; Monitoring of antibiotic resistance

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; OFLOXACIN; OXACILLIN; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; CITROBACTER FREUNDII; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREVALENCE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERITIDIS; SERRATIA MARCESCENS; SPECIES COMPARISON; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS;

EID: 3843093936     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.3.269     Document Type: Article

References (11)

1. Scheid WM. Managing fluoroquinolone class efficacy. Emerg Inf Dis 2003; 9: 1-9.
2. Romanelli G, Cravarezza P, Pozzi A, et al. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy. J Chemother 2002; 14: 609-17.
3. Mylotte JM, Tayara A, Goodnough S. Epidemiology of bloodstream infection in nursing home residents: evaluation in a large cohort from multiple homes. Clin Infect Dis 2002; 35: 1484-90.
4. Goldstein EJ, Garabedian-Ruffalo SM. Widespread use of fluoroquinolones versus emerging resistance in pneumococci. Clin Infect Dis 2002; 35: 1505-11.
5. Van Kerkhoven D, Peetermans WE, Verbist L, Verhaegen J. Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams. J Antimicrob Chemother 2003; 51: 691-6.
6. Simonsen GS, Smabrekke L, Monnet DL, et al. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J Antimicrob Chemother 2003; 51: 323-31.
7. Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, Ayala JA, Perea EJ, Pascual A. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumanii. J Antimicrob Chemother 2002; 51: 565-74.
8. Ban-Hock T, Ai-Ling. Community-acquired bacteremia with ESBL-producing Escherichia coli. Int J Infect Dis 2002; 6: 318-9.
9. Alobwede I, M'Zali FH, Livermore DM, Heritage J, Todd N, Hawkey PM. CTX-M extended-spectrum beta-lactamase arrives in the UK. J Antimicrob Chemother 2003; 51: 470-1.
10. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 2003; 51: 347-52.
11. Brenwald NP, Jevons G, Andrews JM, Xiong JH, Hawkey PM, Wise R. An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases. J Antimicrob Chemother 2003; 51: 195-6.